Skip to main content
ES
v1.2
Log in
I

Ipca Labs

IPCA LABSNSE
₹1,832.6-80.50 (-4.21%)as of 2026-10-16
Market Cap
₹46,830Cr.
P/E Ratio
34.1
P/B Ratio
5.76
EPS (TTM)
₹53.74
Day Range
₹1,813.2 – ₹1,907.1
Div Yield
0.31%
ROCE
17%
ROE
15.7%
52W Low: ₹1,25252W High: ₹2,038
Themes:💊 Pharma & CDMO
Appears in 1 screen
🛡️Low-Volatility Defensives
97
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 16.0% a year over three years.
  • Debt is 0.10× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Ipca_Labs — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5.8/ 10Overall
5/ 10Valuation
7/ 10Quality
4/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 34.1P/E: 34.1 | P/B: 5.76
Growth
GrowingSales CAGR — 3Y: 16% · 1Y: 11%
Profitability
ModerateROCE: 17% | ROE: 15.7%

Key Metrics

Valuation
PEG Ratio 0.92
Price / Sales 4.62x
Price / FCF 96.4x
Book Value ₹318
Margins & returns
Operating Margin 22%
Net Margin 13.6%
Return on Assets 11.1%

Frequently Asked Questions

MarketsPortfolioChart